Colorado Clinical and Translational Sciences Institute (CCTSI) News and Stories

This month, Barbara Hammack, PhD is retiring after dedicating 23 years to clinical research at the University of Colorado Anschutz Medical Campus. After receiving her PhD in theoretical biophysics, she took a fellowship in the Department of Neurology, investigating Multiple Sclerosis and its causes. A few years later, she worked on studies related to amyotrophic lateral sclerosis (ALS) and complications from shingles.

Wendy Meyer | March 09, 2023

Clinical research is one of the primary reasons the University of Colorado Anschutz Medical Campus is a nationally renowned healthcare destination. Yet in 2019, only 25% of CU Anschutz adult clinical trials enrolled even one participant over age 50. Study results may not apply to unrepresented populations, so the National Institutes of Health (NIH) requires clinical research to include individuals across the life span.

Wendy Meyer | November 02, 2022

1. CCTSI stands for the Colorado Clinical and Translational Sciences Institute.

2. We help build the research teams of the future, speed the development of new treatments and improve human health

Wendy Meyer | September 14, 2021

The CCTSI is pleased to announce two new leadership roles: Jose R. Castillo-Mancilla, MD and Christopher D. Baker, MD will each serve as Associate Medical Director of the Clinical and Translational Research Centers of the CCTSI. Dr. Baker will oversee the pediatric CTRC at Children’s Hospital Colorado under the leadership of Medical Director Dr. Phil Zeitler. Dr. Castillo-Mancia will oversee the adult CTRC at UCHealth under the leadership of Medical Director Dr. Tom Campbell.

Wendy Meyer | June 24, 2021

The nation has been coping with the pandemic for more than a year, and in this time, researchers have learned a great deal about how to treat COVID-19. Yet they have also been faced with what they still must learn, including how to reach the individuals who have been most dramatically impacted by the disease and who could benefit the most from new treatments. 

Wendy Meyer | March 30, 2021